eClinical UX & Digital Strategy for Global CROs

Patient drop-out is the most costly risk in clinical research. We design ePRO and eConsent applications with behavioral UX principles: intuitive daily check-ins, accessible typography, and smart reminder flows. By removing interface friction from the patient journey, we significantly reduce non-compliance rates and keep participants enrolled from screening to database lock across both centralized and decentralized trial models.

IRBs require eConsent interfaces that demonstrably ensure participant comprehension. We design layered consent flows with plain-language summaries, embedded video explanations, knowledge checks, and accessible reading levels. Our eConsent UX deliverables are structured to pass ethics committee review at first submission, minimizing amendment cycles and protecting your study timeline.

Yes. The majority of EDC queries originate from poorly structured forms and ambiguous field labels. We redesign data capture interfaces with logical field grouping, contextual inline validation, and smart skip logic, ensuring that site coordinators can enter data accurately in fewer interactions. This directly reduces query backlogs and accelerates database lock for sponsors.

Decentralized and hybrid trials require patient-facing digital products that work reliably across diverse devices, connectivity levels, and health literacy backgrounds. We design DCT ecosystems encompassing patient mobile apps, remote monitoring dashboards, and teleconsultation flows, ensuring that geographically dispersed participants remain engaged and compliant regardless of their location or technical proficiency.

Yes. Investigator portals are critical for site performance. We design secure, role-based environments that centralize protocol documentation, patient recruitment tracking, compliance checklists, and regulatory submissions in a single streamlined workspace. Our investigator UX significantly reduces the administrative burden on site coordinators and research nurses across multi-site global studies.

Absolutely. We have direct operational experience with clinical research organizations in Algeria and France, and we serve sponsors across the MENA region, Europe, and North America. Our bilingual French-English team understands local regulatory frameworks and provides culturally adapted UX, including Right-to-Left (RTL) Arabic interface support for patient recruitment and eConsent platforms deployed in North Africa and the Middle East.

Yes. We integrate AI-driven UX components into clinical digital experiences: adaptive onboarding that adjusts to patient literacy, intelligent symptom diary prompts that increase ePRO completion rates, and predictive UI patterns that flag likely drop-out signals. These AI-enhanced design layers improve patient engagement while keeping every data interaction aligned with GCP and IRB requirements.

Clinical research data is among the most sensitive information handled in any industry. We operate under strict non-disclosure agreements (NDAs) for every mandate. Our digital architectures implement role-based access control, non-repudiable audit logs, and end-to-end encryption aligned with FDA 21 CFR Part 11, EMA Annex 11, ICH E6 (R2) GCP, and GDPR requirements to fully protect participant data and sponsor intellectual property.